Lepu Historical Cash Flow

300003 Stock   12.03  0.03  0.25%   
Analysis of Lepu Medical cash flow over time is an excellent tool to project Lepu Medical Tech future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 467.2 M or Total Cash From Operating Activities of 1.1 B as it is a great indicator of Lepu Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Lepu Medical Tech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lepu Medical Tech is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Lepu Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Lepu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Lepu's non-liquid assets can be easily converted into cash.

Lepu Medical Cash Flow Chart

At present, Lepu Medical's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 1.1 B, whereas Other Cashflows From Financing Activities is forecasted to decline to (205.7 M).

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Lepu Medical Tech to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Lepu Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Lepu Medical Tech financial statement analysis. It represents the amount of money remaining after all of Lepu Medical Tech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
Most accounts from Lepu Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Lepu Medical Tech current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Lepu Medical Tech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, Lepu Medical's Dividends Paid is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 1.1 B, whereas Other Cashflows From Financing Activities is forecasted to decline to (205.7 M).
 2021 2022 2023 2024 (projected)
Capital Expenditures984.4M905.2M844.7M467.2M
Dividends Paid587.0M635.6M768.7M807.1M

Lepu Medical cash flow statement Correlations

0.81-0.17-0.39-0.36-0.260.780.540.720.160.630.580.080.50.74
0.81-0.4-0.26-0.22-0.610.860.750.590.090.680.860.190.420.84
-0.17-0.4-0.35-0.430.64-0.49-0.51-0.22-0.61-0.5-0.64-0.29-0.18-0.3
-0.39-0.26-0.350.650.16-0.48-0.47-0.67-0.26-0.570.170.66-0.7-0.21
-0.36-0.22-0.430.650.21-0.39-0.4-0.530.01-0.120.220.71-0.48-0.48
-0.26-0.610.640.160.21-0.75-0.86-0.58-0.52-0.67-0.590.18-0.56-0.54
0.780.86-0.49-0.48-0.39-0.750.920.820.470.880.65-0.170.760.75
0.540.75-0.51-0.47-0.4-0.860.920.770.490.810.59-0.230.670.68
0.720.59-0.22-0.67-0.53-0.580.820.770.630.820.33-0.40.790.63
0.160.09-0.61-0.260.01-0.520.470.490.630.660.07-0.40.640.13
0.630.68-0.5-0.57-0.12-0.670.880.810.820.660.54-0.180.810.46
0.580.86-0.640.170.22-0.590.650.590.330.070.540.580.10.66
0.080.19-0.290.660.710.18-0.17-0.23-0.4-0.4-0.180.58-0.62-0.02
0.50.42-0.18-0.7-0.48-0.560.760.670.790.640.810.1-0.620.36
0.740.84-0.3-0.21-0.48-0.540.750.680.630.130.460.66-0.020.36
Click cells to compare fundamentals

Lepu Medical Account Relationship Matchups

Lepu Medical cash flow statement Accounts

201920202021202220232024 (projected)
Other Cashflows From Financing Activities(1.3B)(372.4M)(66.1M)(217.7M)(195.9M)(205.7M)
Dividends Paid639.2M598.4M587.0M635.6M768.7M807.1M
Capital Expenditures563.1M600.1M984.4M905.2M844.7M467.2M
Total Cash From Operating Activities2.0B2.1B3.1B2.8B990.4M1.1B
Net Income1.7B1.8B1.7B2.2B1.3B1.0B
Other Cashflows From Investing Activities169.0M225.6M(210.3M)533.3M613.3M643.9M
Total Cash From Financing Activities767.6M(1.5B)(763.4M)(897.4M)(807.7M)(767.3M)
Change To Inventory(205.6M)(422.9M)(494.7M)(386.7M)(251.0M)(263.6M)
Investments53.5M17.8M129.2M(1.6B)(1.9B)(1.8B)
Change In Cash(205.4M)599.6M1.3B1.6B(1.2B)(1.1B)
Net Borrowings2.6B(537.3M)(98.9M)(592.5M)(533.3M)(506.6M)
Total Cashflows From Investing Activities(2.3B)(651.2M)(695.5M)(860.5M)(989.5M)(1.0B)
Depreciation284.5M388.2M448.7M488.5M513.6M349.5M
Change To Account Receivables(504.5M)(252.5M)(32.7M)42.8M49.3M51.7M
Change To Netincome441.2M339.9M104.9M678.9M780.8M819.8M
Change To Liabilities165.8M58.0M195.3M594.0M683.1M717.3M
End Period Cash Flow1.8B2.4B3.7B5.3B4.1B3.2B
Free Cash Flow1.4B1.5B2.1B1.9B145.7M138.4M
Change In Working Capital(379.9M)(290.0M)142.1M(355.2M)(1.3B)(1.2B)
Begin Period Cash Flow2.0B1.8B2.4B3.7B5.3B3.0B
Other Non Cash Items362.3M323.8M301.3M267.9M260.9M308.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Lepu Stock

The Cash Flow Statement is a financial statement that shows how changes in Lepu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Lepu's non-liquid assets can be easily converted into cash.